Neuroprotection and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Neuroprotection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neuroprotection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neuroprotection Overall Market Size
2.1 Global Neuroprotection Market Size: 2022 VS 2029
2.2 Global Neuroprotection Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Neuroprotection Players in Global Market
3.2 Top Global Neuroprotection Companies Ranked by Revenue
3.3 Global Neuroprotection Revenue by Companies
3.4 Top 3 and Top 5 Neuroprotection Companies in Global Market, by Revenue in 2022
3.5 Global Companies Neuroprotection Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuroprotection Players in Global Market
3.6.1 List of Global Tier 1 Neuroprotection Companies
3.6.2 List of Global Tier 2 and Tier 3 Neuroprotection Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Neuroprotection Market Size Markets, 2022 & 2029
4.1.2 Free Anti-Inflammatory Agents
4.1.3 Radical Trapping Agents (Antioxidants)
4.1.4 Apoptosis Inhibitors
4.1.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
4.1.6 Neurotrophic Factors (NTFs)
4.1.7 Stimulants
4.1.8 Metal Ion Chelators
4.1.9 Others
4.2 By Type - Global Neuroprotection Revenue & Forecasts
4.2.1 By Type - Global Neuroprotection Revenue, 2018-2023
4.2.2 By Type - Global Neuroprotection Revenue, 2024-2029
4.2.3 By Type - Global Neuroprotection Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neuroprotection Market Size, 2022 & 2029
5.1.2 Prevention
5.1.3 Treatment
5.2 By Application - Global Neuroprotection Revenue & Forecasts
5.2.1 By Application - Global Neuroprotection Revenue, 2018-2023
5.2.2 By Application - Global Neuroprotection Revenue, 2024-2029
5.2.3 By Application - Global Neuroprotection Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Neuroprotection Market Size, 2022 & 2029
6.2 By Region - Global Neuroprotection Revenue & Forecasts
6.2.1 By Region - Global Neuroprotection Revenue, 2018-2023
6.2.2 By Region - Global Neuroprotection Revenue, 2024-2029
6.2.3 By Region - Global Neuroprotection Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Neuroprotection Revenue, 2018-2029
6.3.2 US Neuroprotection Market Size, 2018-2029
6.3.3 Canada Neuroprotection Market Size, 2018-2029
6.3.4 Mexico Neuroprotection Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Neuroprotection Revenue, 2018-2029
6.4.2 Germany Neuroprotection Market Size, 2018-2029
6.4.3 France Neuroprotection Market Size, 2018-2029
6.4.4 U.K. Neuroprotection Market Size, 2018-2029
6.4.5 Italy Neuroprotection Market Size, 2018-2029
6.4.6 Russia Neuroprotection Market Size, 2018-2029
6.4.7 Nordic Countries Neuroprotection Market Size, 2018-2029
6.4.8 Benelux Neuroprotection Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Neuroprotection Revenue, 2018-2029
6.5.2 China Neuroprotection Market Size, 2018-2029
6.5.3 Japan Neuroprotection Market Size, 2018-2029
6.5.4 South Korea Neuroprotection Market Size, 2018-2029
6.5.5 Southeast Asia Neuroprotection Market Size, 2018-2029
6.5.6 India Neuroprotection Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Neuroprotection Revenue, 2018-2029
6.6.2 Brazil Neuroprotection Market Size, 2018-2029
6.6.3 Argentina Neuroprotection Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Neuroprotection Revenue, 2018-2029
6.7.2 Turkey Neuroprotection Market Size, 2018-2029
6.7.3 Israel Neuroprotection Market Size, 2018-2029
6.7.4 Saudi Arabia Neuroprotection Market Size, 2018-2029
6.7.5 UAE Neuroprotection Market Size, 2018-2029
7 Neuroprotection Companies Profiles
7.1 F. Hoffmann-La Roche
7.1.1 F. Hoffmann-La Roche Company Summary
7.1.2 F. Hoffmann-La Roche Business Overview
7.1.3 F. Hoffmann-La Roche Neuroprotection Major Product Offerings
7.1.4 F. Hoffmann-La Roche Neuroprotection Revenue in Global Market (2018-2023)
7.1.5 F. Hoffmann-La Roche Key News & Latest Developments
7.2 Eli Lilly and Company
7.2.1 Eli Lilly and Company Company Summary
7.2.2 Eli Lilly and Company Business Overview
7.2.3 Eli Lilly and Company Neuroprotection Major Product Offerings
7.2.4 Eli Lilly and Company Neuroprotection Revenue in Global Market (2018-2023)
7.2.5 Eli Lilly and Company Key News & Latest Developments
7.3 Daiichi Sankyo Company
7.3.1 Daiichi Sankyo Company Company Summary
7.3.2 Daiichi Sankyo Company Business Overview
7.3.3 Daiichi Sankyo Company Neuroprotection Major Product Offerings
7.3.4 Daiichi Sankyo Company Neuroprotection Revenue in Global Market (2018-2023)
7.3.5 Daiichi Sankyo Company Key News & Latest Developments
7.4 Allergan
7.4.1 Allergan Company Summary
7.4.2 Allergan Business Overview
7.4.3 Allergan Neuroprotection Major Product Offerings
7.4.4 Allergan Neuroprotection Revenue in Global Market (2018-2023)
7.4.5 Allergan Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Neuroprotection Major Product Offerings
7.5.4 Novartis Neuroprotection Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Neuroprotection Major Product Offerings
7.6.4 AstraZeneca Neuroprotection Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Dr. Reddy's Laboratories
7.7.1 Dr. Reddy's Laboratories Company Summary
7.7.2 Dr. Reddy's Laboratories Business Overview
7.7.3 Dr. Reddy's Laboratories Neuroprotection Major Product Offerings
7.7.4 Dr. Reddy's Laboratories Neuroprotection Revenue in Global Market (2018-2023)
7.7.5 Dr. Reddy's Laboratories Key News & Latest Developments
7.8 Astrocyte Pharmaceuticals
7.8.1 Astrocyte Pharmaceuticals Company Summary
7.8.2 Astrocyte Pharmaceuticals Business Overview
7.8.3 Astrocyte Pharmaceuticals Neuroprotection Major Product Offerings
7.8.4 Astrocyte Pharmaceuticals Neuroprotection Revenue in Global Market (2018-2023)
7.8.5 Astrocyte Pharmaceuticals Key News & Latest Developments
7.9 Teva Pharmaceutical Industries
7.9.1 Teva Pharmaceutical Industries Company Summary
7.9.2 Teva Pharmaceutical Industries Business Overview
7.9.3 Teva Pharmaceutical Industries Neuroprotection Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Neuroprotection Revenue in Global Market (2018-2023)
7.9.5 Teva Pharmaceutical Industries Key News & Latest Developments
7.10 Biogen
7.10.1 Biogen Company Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Neuroprotection Major Product Offerings
7.10.4 Biogen Neuroprotection Revenue in Global Market (2018-2023)
7.10.5 Biogen Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Neuroprotection Market Opportunities & Trends in Global Market
Table 2. Neuroprotection Market Drivers in Global Market
Table 3. Neuroprotection Market Restraints in Global Market
Table 4. Key Players of Neuroprotection in Global Market
Table 5. Top Neuroprotection Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Neuroprotection Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Neuroprotection Revenue Share by Companies, 2018-2023
Table 8. Global Companies Neuroprotection Product Type
Table 9. List of Global Tier 1 Neuroprotection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Neuroprotection Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Neuroprotection Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Neuroprotection Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Neuroprotection Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Neuroprotection Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Neuroprotection Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Neuroprotection Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Neuroprotection Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Neuroprotection Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Neuroprotection Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Neuroprotection Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Neuroprotection Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Neuroprotection Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Neuroprotection Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Neuroprotection Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Neuroprotection Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Neuroprotection Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Neuroprotection Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Neuroprotection Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Neuroprotection Revenue, (US$, Mn), 2024-2029
Table 30. F. Hoffmann-La Roche Company Summary
Table 31. F. Hoffmann-La Roche Neuroprotection Product Offerings
Table 32. F. Hoffmann-La Roche Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 33. F. Hoffmann-La Roche Key News & Latest Developments
Table 34. Eli Lilly and Company Company Summary
Table 35. Eli Lilly and Company Neuroprotection Product Offerings
Table 36. Eli Lilly and Company Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 37. Eli Lilly and Company Key News & Latest Developments
Table 38. Daiichi Sankyo Company Company Summary
Table 39. Daiichi Sankyo Company Neuroprotection Product Offerings
Table 40. Daiichi Sankyo Company Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 41. Daiichi Sankyo Company Key News & Latest Developments
Table 42. Allergan Company Summary
Table 43. Allergan Neuroprotection Product Offerings
Table 44. Allergan Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 45. Allergan Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Neuroprotection Product Offerings
Table 48. Novartis Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Neuroprotection Product Offerings
Table 52. AstraZeneca Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Dr. Reddy's Laboratories Company Summary
Table 55. Dr. Reddy's Laboratories Neuroprotection Product Offerings
Table 56. Dr. Reddy's Laboratories Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 57. Dr. Reddy's Laboratories Key News & Latest Developments
Table 58. Astrocyte Pharmaceuticals Company Summary
Table 59. Astrocyte Pharmaceuticals Neuroprotection Product Offerings
Table 60. Astrocyte Pharmaceuticals Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 61. Astrocyte Pharmaceuticals Key News & Latest Developments
Table 62. Teva Pharmaceutical Industries Company Summary
Table 63. Teva Pharmaceutical Industries Neuroprotection Product Offerings
Table 64. Teva Pharmaceutical Industries Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 65. Teva Pharmaceutical Industries Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Neuroprotection Product Offerings
Table 68. Biogen Neuroprotection Revenue (US$, Mn) & (2018-2023)
Table 69. Biogen Key News & Latest Developments
List of Figures
Figure 1. Neuroprotection Segment by Type in 2022
Figure 2. Neuroprotection Segment by Application in 2022
Figure 3. Global Neuroprotection Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Neuroprotection Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Neuroprotection Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Neuroprotection Revenue in 2022
Figure 8. By Type - Global Neuroprotection Revenue Market Share, 2018-2029
Figure 9. By Application - Global Neuroprotection Revenue Market Share, 2018-2029
Figure 10. By Type - Global Neuroprotection Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Neuroprotection Revenue Market Share, 2018-2029
Figure 12. By Application - Global Neuroprotection Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Neuroprotection Revenue Market Share, 2018-2029
Figure 14. By Region - Global Neuroprotection Revenue Market Share, 2018-2029
Figure 15. By Country - North America Neuroprotection Revenue Market Share, 2018-2029
Figure 16. US Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Neuroprotection Revenue Market Share, 2018-2029
Figure 20. Germany Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 21. France Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Neuroprotection Revenue Market Share, 2018-2029
Figure 28. China Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 32. India Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Neuroprotection Revenue Market Share, 2018-2029
Figure 34. Brazil Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Neuroprotection Revenue Market Share, 2018-2029
Figure 37. Turkey Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Neuroprotection Revenue, (US$, Mn), 2018-2029
Figure 41. F. Hoffmann-La Roche Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Eli Lilly and Company Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Daiichi Sankyo Company Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Allergan Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Dr. Reddy's Laboratories Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astrocyte Pharmaceuticals Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Teva Pharmaceutical Industries Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Biogen Neuroprotection Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Industry Market Size
